Helicobacter Pylori eradication increases telomere length in gastric mucosa

Hepato-Gastroenterology

Volumn 60, Issue 123, 2013, Pages 601-604

  Aslan, Rahmi ^a   Bektas, Ahmet ^a   Bedir, Abdulkerim ^a   Alacam, Hasan ^a   Aslan, Melek Suzer ^b   Nar, Rukiye ^c   Yildirim, Beytullah ^a   Goren, Ibrahim ^a   Ecemis, Ozgur ^d   Ustaoglu, Muge ^e   Goren, Fikret ^a   Okuyucu, Ali ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^b Bafra State Hospital   (Turkey)

^c Aksaray State Hospital   (Turkey)

^d Nigde State Hospital   (Turkey)

^e Trabzon Kanuni Education and Research Hospital   (Turkey)

Author keywords

Helicobacter pylori; PCR ELISA; RT PCR; Telomerase activity; Telomere length

Indexed keywords

AMOXICILLIN; BISMUTH; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE;

ADULT; ARTICLE; BACTERIAL CLEARANCE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HELICOBACTER INFECTION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH MUCOSA; TELOMERE;

ADULT; ANTI-BACTERIAL AGENTS; BIOPSY; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTRIC MUCOSA; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; PROTON PUMP INHIBITORS; TELOMERASE; TELOMERE; TELOMERE HOMEOSTASIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84879562222     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge12691     Document Type: Article

References (28)

1. Suerbaum S, Michetti P: Helicobacter pylori infection. N Engl J Med 2002; 347:1175-1186.
2. Alakkari A, Zullo A, O'Connor HJ: Helicobacter pylori and non-malignant diseases. Helicobacter 2011; 16:33-37.
3. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process. First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992; 52:6735-6740.
4. Helicobacter and Cancer Collaborative Group: Gastric cancer and Helicobacter pylori: A combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49:347-353.
5. Callen E, Surrallés J: Telomere dysfunction in genome instability syndromes. Mutat Res 2004; 567:85-104. (Pubitemid 39162995)
6. Wentzensen IM, Mirabello L, Pfeiffer RM, Savage SA: The association of telomere length and cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2011; 20:1238-1250.
7. Mu Y, Zhang Q, Mei L, Liu X, Yang W, Yu J: Telomere shortening occurs early during gastrocarcinogenesis. Med Oncol 2012; 29:893-898.
8. Zvereva MI, Shcherbakova DM, Dontsova OA: Telomerase: structure, functions, and activity regulation. Biochemistry (Mosc) 2010; 75:1563-1583.
9. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33:787-791.
10. Avilion AA, Piatyszek MA, Gupta J, et al.: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56:645-650. (Pubitemid 26043667)
11. Cawthon RM: Telomere measurement by quantitative PCR. Nucleic Acids Res 2002; 30:e47.
12. Monaghan P: Telomeres and life histories: the long and the short of it. Ann NY Acad Sci 2010; 1206:130-142.
13. Takai H, Smogorzewska A, de Lange T: DNA damage foci at dysfunctional telomeres. Curr Biol 2003; 13:1549-1556. (Pubitemid 37078413)
14. Houben JM, Moonen HJ, van Schooten FJ, Hageman GJ: Telomere length assessment: biomarker of chronic oxidative stress? Free Radic Biol Med 2008; 44:235-246.
15. Kawanishi S, Oikawa S: Mechanism of telomere shortening by oxidative stres. Ann NY Acad Sci 2004; 1019:278-284. (Pubitemid 38951320)
16. Petersen S, Saretzki G, von Zglinicki T: Preferential accumulation of single-stranded regions in telomeres of human fibroblasts. Exp Cell Res 1998; 239:152-160. (Pubitemid 28368486)
17. Davies GR, Simmonds NJ, Stevens TR, et al.: Helicobacter pylori stimulates antral mucosal reactive oxygen metabolite production in vivo. Gut 1994; 35:179-185. (Pubitemid 24092862)
18. Zhang QB, Nakashabendi IM, Mokhashi MS, et al.: Association of cytotoxin production and neutrophil activation by strains of Helicobacter pylori isolated from patients with peptic ulceration and chronic gastritis. Gut 1996; 38:841-845. (Pubitemid 26231767)
19. Farkas R, Pronai L, Tulassay Z, Selmecl L: Relationship between eradication of Helicobacter pylori and gastric mucosal superoxide dismutase activity. Anticancer Res 2005; 25:4763-4767. (Pubitemid 41729544)
20. Nagata K, Yu H, Nishikawa M, et al.: Helicobacter pylori generates superoxide radicals and modulates nitric oxide metabolism. J Biol Chem 1998; 273:14071-14073. (Pubitemid 28319110)
21. Duiger AC, Aslan M, Nazligui Y, et al.: A peripheral lymphocyte DNA damage and oxidative status after eradication therapy in patients infected with Helicobacter pylori. Pol Arch Med Wewn 2011; 121:428-432.
22. Kuniyasu H, Kitadai Y, Mieno H, Yasui W: Helicobacter pylori infection is closely associated with telomere reduction in gastric mucosa. Oncology 2003; 65:275-282. (Pubitemid 37505836)
23. Liu X, Bao G, Huo T, Wang Z, He X, Dong G: Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population. Cancer Sci 2009; 100:1300-1305.
24. Zhang GX, Gu YH, Zhao ZQ, et al.: Coordinate increase of telomerase activity and c-Myc expression in Helicobacter pylori-associated gastric diseases. World J Gastroenterol 2004; 10:1759-1762.
25. Lan J, Xiong YY, Lin YX, et al.: Helicobacter pylori infection generated gastric cancer through p53-Rb tumor-suppressor system mutation and telomerase reactivation. World J Gastroenterol 2003; 9:54-58. (Pubitemid 36131278)
26. Kameshima H, Yagihashi A, Yajima T, et al.: Helicobacter pylori infection: augmentation of telomerase activity in cancer and non-cancerous tissues. World J Surg 2000; 24:1243-1249.
27. Hiyama E, Yokoyama T, Tatsumoto N, et al.: Telomerase activity in gastric cancer. Cancer Res 1995; 55:3258-3262.
28. Maruyama Y, Hanai H, Fujita M, et al.: Telomere length and telomerase activity in carcinogenesis of the stomach. Jpn J Clin Oncol 1997; 27:216-220. (Pubitemid 127516767)